Secondary osteoporosis: a review of the recent evidence
- PMID: 16901802
- DOI: 10.4158/EP.12.4.436
Secondary osteoporosis: a review of the recent evidence
Abstract
Objective: To review several causes of secondary osteoporosis as well as screening recommendations for underlying disorders.
Methods: We conducted a review of the literature on many of the causes of osteoporosis that have been published during the past 15 years, focusing on those sources available from 2000 through the present. Indeed, more than two-thirds of the articles that we reviewed were printed during the past 6 years. These reports examined secondary osteoporosis in general, as well as many of the specific causes.
Results: Secondary osteoporosis occurs in almost two-thirds of men, more than half of premenopausal and perimenopausal women, and about one-fifth of postmenopausal women. Its causes are vast, and they include hypogonadism, medications, hyperthyroidism, vitamin D deficiency, primary hyperparathyroidism, solid organ transplantation, gastrointestinal diseases, hematologic diseases, Cushing's syndrome, and idiopathic hypercalciuria. These causes have their own pathogenesis, epidemiologic features, and effect on the skeleton.
Conclusion: The causes of secondary osteoporosis are numerous, and an understanding of their characteristics with respect to bone density and potential fracture risk is essential in the management of osteoporosis. A heightened awareness of the possibility of their existence is necessary to provide optimal care.
Similar articles
-
Secondary causes of osteoporosis.Endocr Pract. 2013 Jan-Feb;19(1):120-8. doi: 10.4158/EP12059.RA. Endocr Pract. 2013. PMID: 23186949 Review.
-
Secondary osteoporosis: differential diagnosis and workup.Clin Obstet Gynecol. 2013 Dec;56(4):686-93. doi: 10.1097/GRF.0b013e3182a9b5f9. Clin Obstet Gynecol. 2013. PMID: 24100597 Review.
-
[Osteoporosis after solid organs transplantation].Arq Bras Endocrinol Metabol. 2005 Jun;49(3):369-77. doi: 10.1590/s0004-27302005000300007. Epub 2006 Mar 16. Arq Bras Endocrinol Metabol. 2005. PMID: 16543990 Review. Portuguese.
-
Differential diagnosis and secondary causes of osteoporosis.Clin Cornerstone. 2000;2(6):11-21. doi: 10.1016/s1098-3597(00)90002-4. Clin Cornerstone. 2000. PMID: 10938988
-
Osteoporosis in men: the value of laboratory testing.Osteoporos Int. 2011 Jun;22(6):1845-53. doi: 10.1007/s00198-010-1421-0. Epub 2010 Oct 9. Osteoporos Int. 2011. PMID: 20936403
Cited by
-
The Treatment Gap in Osteoporosis.J Clin Med. 2021 Jul 5;10(13):3002. doi: 10.3390/jcm10133002. J Clin Med. 2021. PMID: 34279485 Free PMC article. Review.
-
Effects of weight training time on bone mineral density of patients with secondary osteoporosis after hemiplegia.Exp Ther Med. 2017 Mar;13(3):961-965. doi: 10.3892/etm.2017.4078. Epub 2017 Jan 23. Exp Ther Med. 2017. PMID: 28450926 Free PMC article.
-
Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types.Elife. 2022 Aug 9;11:e76228. doi: 10.7554/eLife.76228. Elife. 2022. PMID: 35942681 Free PMC article.
-
A novel index to assess low energy fracture risks in patients prescribed antiepileptic drugs.PLoS One. 2021 Aug 26;16(8):e0256093. doi: 10.1371/journal.pone.0256093. eCollection 2021. PLoS One. 2021. PMID: 34437569 Free PMC article.
-
Increased levels of interleukin 31 (IL-31) in osteoporosis.BMC Immunol. 2015 Oct 8;16:60. doi: 10.1186/s12865-015-0125-9. BMC Immunol. 2015. PMID: 26449657 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
